Related Experiment Video
Updated: Jul 13, 2026
08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
A mathematical model for M-phase specific chemotherapy including the G0-phase and immunoresponse
Wenxiang Liu1, Thomas Hillen, H I Freedman
1Department of Mathematical and Statistical Sciences, University of Alberta, Edmonton, T6G 2G1, Canada. wliu@math.ualberta.ca
Mathematical Biosciences and Engineering : MBE
|July 31, 2007
Summary
A mathematical model reveals that cancer cells in the resting G(0) phase can evade M-phase specific drugs. The dynamics of the G(0) phase are crucial for overall cancer progression and treatment response.
Area of Science:
- Mathematical oncology
- Cancer cell cycle dynamics
- Immunology
Background:
- Cancer cell proliferation is regulated by the cell cycle, comprising distinct phases like M-phase and G(0) (resting) phase.
- M-phase specific drugs target rapidly dividing cells, but their efficacy can be limited by cancer cell heterogeneity.
- The interplay between cancer cells, including quiescent populations, and the immune system is critical in tumor development.
Purpose of the Study:
- To investigate the impact of an M-phase specific drug on cancer development using a mathematical model.
- To analyze the role of the G(0) resting phase and immune response in cancer progression under drug treatment.
- To explore the potential of cell synchronization as a treatment strategy.
Main Methods:
- Development of a mathematical model incorporating M-phase, G(0)-phase, and interphase (G(1), S, G(2)) of the cancer cell cycle.
- Inclusion of a time delay for interphase passage and interaction between immune cells and all cancer cells.
- Analytical and numerical analysis of the cancer-free equilibrium stability and Hopf bifurcation for oscillatory dynamics.
Main Results:
- Quiescent cancer cells (G(0)-phase) can evade M-phase specific drugs, highlighting a mechanism of drug resistance.
- The dynamics of the G(0) phase significantly influence the overall cancer progression and treatment outcomes.
- The model predicts oscillatory cancer dynamics through a Hopf bifurcation, suggesting complex temporal behaviors.
- The study evaluates the effectiveness of cell synchronization as a pre-treatment strategy.
Conclusions:
- Cancer cell dormancy in the G(0) phase presents a significant challenge for M-phase targeted therapies.
- Understanding and targeting the G(0) phase dynamics are essential for effective cancer treatment strategies.
- Cell synchronization prior to drug administration may offer a method to enhance therapeutic efficacy.
Related Concept Videos
01:29Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:28The Cell Cycle Control System
The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...